These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 25709032

  • 1. Fragment library design: using cheminformatics and expert chemists to fill gaps in existing fragment libraries.
    Kutchukian PS, So SS, Fischer C, Waller CL.
    Methods Mol Biol; 2015; 1289():43-53. PubMed ID: 25709032
    [Abstract] [Full Text] [Related]

  • 2. Charting, navigating, and populating natural product chemical space for drug discovery.
    Lachance H, Wetzel S, Kumar K, Waldmann H.
    J Med Chem; 2012 Jul 12; 55(13):5989-6001. PubMed ID: 22537178
    [Abstract] [Full Text] [Related]

  • 3. Fragment-based approaches in drug discovery and chemical biology.
    Scott DE, Coyne AG, Hudson SA, Abell C.
    Biochemistry; 2012 Jun 26; 51(25):4990-5003. PubMed ID: 22697260
    [Abstract] [Full Text] [Related]

  • 4. Efficient search of chemical space: navigating from fragments to structurally diverse chemotypes.
    Wassermann AM, Kutchukian PS, Lounkine E, Luethi T, Hamon J, Bocker MT, Malik HA, Cowan-Jacob SW, Glick M.
    J Med Chem; 2013 Nov 14; 56(21):8879-91. PubMed ID: 24117015
    [Abstract] [Full Text] [Related]

  • 5. Large scale meta-analysis of fragment-based screening campaigns: privileged fragments and complementary technologies.
    Kutchukian PS, Wassermann AM, Lindvall MK, Wright SK, Ottl J, Jacob J, Scheufler C, Marzinzik A, Brooijmans N, Glick M.
    J Biomol Screen; 2015 Jun 14; 20(5):588-96. PubMed ID: 25550355
    [Abstract] [Full Text] [Related]

  • 6. Cheminformatics approaches to analyze diversity in compound screening libraries.
    Akella LB, DeCaprio D.
    Curr Opin Chem Biol; 2010 Jun 14; 14(3):325-30. PubMed ID: 20457001
    [Abstract] [Full Text] [Related]

  • 7. Recent trends and observations in the design of high-quality screening collections.
    Renner S, Popov M, Schuffenhauer A, Roth HJ, Breitenstein W, Marzinzik A, Lewis I, Krastel P, Nigsch F, Jenkins J, Jacoby E.
    Future Med Chem; 2011 Apr 14; 3(6):751-66. PubMed ID: 21554080
    [Abstract] [Full Text] [Related]

  • 8. Fragment-based design of kinase inhibitors: a practical guide.
    Erickson JA.
    Methods Mol Biol; 2015 Apr 14; 1289():157-83. PubMed ID: 25709040
    [Abstract] [Full Text] [Related]

  • 9. FRAGMENTISE: A user-friendly, cross-platform tool to create and analyze comprehensive small-molecule fragment databases.
    Zarnecka JM, Kaminska KH.
    J Comput Chem; 2023 Oct 05; 44(26):2096-2102. PubMed ID: 37381904
    [Abstract] [Full Text] [Related]

  • 10. Enhancements of screening collections to address areas of unmet medical need: an industry perspective.
    Drewry DH, Macarron R.
    Curr Opin Chem Biol; 2010 Jun 05; 14(3):289-98. PubMed ID: 20413343
    [Abstract] [Full Text] [Related]

  • 11. Fragment-Based Ligand Designing.
    Katiyar SP, Malik V, Kumari A, Singh K, Sundar D.
    Methods Mol Biol; 2018 Jun 05; 1762():123-144. PubMed ID: 29594771
    [Abstract] [Full Text] [Related]

  • 12. Efficient exploration of chemical space by fragment-based screening.
    Hall RJ, Mortenson PN, Murray CW.
    Prog Biophys Mol Biol; 2014 Jun 05; 116(2-3):82-91. PubMed ID: 25268064
    [Abstract] [Full Text] [Related]

  • 13. Twenty years on: the impact of fragments on drug discovery.
    Erlanson DA, Fesik SW, Hubbard RE, Jahnke W, Jhoti H.
    Nat Rev Drug Discov; 2016 Sep 05; 15(9):605-619. PubMed ID: 27417849
    [Abstract] [Full Text] [Related]

  • 14. Increasing the delivery of next generation therapeutics from high throughput screening libraries.
    Wigglesworth MJ, Murray DC, Blackett CJ, Kossenjans M, Nissink JW.
    Curr Opin Chem Biol; 2015 Jun 05; 26():104-10. PubMed ID: 25909818
    [Abstract] [Full Text] [Related]

  • 15. From fragment screening to potent binders: strategies for fragment-to-lead evolution.
    Eitner K, Koch U.
    Mini Rev Med Chem; 2009 Jul 05; 9(8):956-61. PubMed ID: 19601891
    [Abstract] [Full Text] [Related]

  • 16. Using DNA-encoded libraries of fragments for hit discovery of challenging therapeutic targets.
    Zhao G, Zhu M, Li Y, Zhang G, Li Y.
    Expert Opin Drug Discov; 2024 Jun 05; 19(6):725-740. PubMed ID: 38753553
    [Abstract] [Full Text] [Related]

  • 17. Computational methods for fragment-based ligand design: growing and linking.
    Bienstock RJ.
    Methods Mol Biol; 2015 Jun 05; 1289():119-35. PubMed ID: 25709037
    [Abstract] [Full Text] [Related]

  • 18. Small-Molecule Library Subset Screening as an Aid for Accelerating Lead Identification.
    Beresini MH, Liu Y, Dawes TD, Clark KR, Orren L, Schmidt S, Turincio R, Jones SW, Rodriguez RA, Thana P, Hascall D, Gross DP, Skelton NJ.
    J Biomol Screen; 2014 Jun 05; 19(5):758-70. PubMed ID: 24518067
    [Abstract] [Full Text] [Related]

  • 19. Fragment-based drug design: computational & experimental state of the art.
    Hoffer L, Renaud JP, Horvath D.
    Comb Chem High Throughput Screen; 2011 Jul 05; 14(6):500-20. PubMed ID: 21521152
    [Abstract] [Full Text] [Related]

  • 20. PGVL Hub: An integrated desktop tool for medicinal chemists to streamline design and synthesis of chemical libraries and singleton compounds.
    Peng Z, Yang B, Mattaparti S, Shulok T, Thacher T, Kong J, Kostrowicki J, Hu Q, Na J, Zhou JZ, Klatte D, Chao B, Ito S, Clark J, Sciammetta N, Coner B, Waller C, Kuki A.
    Methods Mol Biol; 2011 Jul 05; 685():295-320. PubMed ID: 20981530
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.